Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 243 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Sinus surgery Clear all

Conditions: Skull Base, Pituitary, Robotics, Endonasal Surgery, Sinus Surgery
Interventions: Use of force sensing surgical curette, Removal of pituitary tumor using modified curette; Device · Procedure
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Chronic Rhinosinusitis
Interventions: 1% Johnson's Baby Shampoo; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Gastrointestinal Disease
Interventions: Gastrointestinal anomalies; Other
Lead sponsor: Children's Hospitals and Clinics of Minnesota; Other
Eligibility: 0 Days to 4 Months
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Abdomen Hernia
Interventions: Prevena, Prineo, Traditional; Device · Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Renal Failure
Interventions: Group 1: Alternative Fistula, Group 2: Forearm AV Graft; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Chronic Rhinosinusitis, Rhinosinusitis, Sinusitis, Drain Sinus, Endoscopic Sinus Surgery, Biofilms, Bacterial Overgrowth
Interventions: Xylitol, Saline; Drug
Lead sponsor: Ochsner Health System; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Total Laryngectomy
Interventions: oral intake; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Pituitary Tumor
Interventions: Nasal saline irrigation; Other
Lead sponsor: Lori Wood; Other
Eligibility: 19 Years to 85 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 2
States / cities: Phoenix, Arizona • Cleveland, Ohio

Conditions: Arteriovenous Fistula Complications and Failure
Interventions: Clipped anastomosis, Handsewn anastomosis; Device · Procedure
Lead sponsor: Gundersen Lutheran Medical Foundation; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: La Crosse, Wisconsin

Conditions: Chronic Sinusitis
Interventions: PROPEL Mini Sinus Implant., Sinus Surgery alone, Propel Nova Sinus Implant; Device · Procedure
Lead sponsor: Intersect ENT; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 10
States / cities: Sacramento, California • Torrance, California • Norwalk, Connecticut + 7 more

Conditions: Paranasal Sinus Disease
Interventions: Bacitracin; Drug
Lead sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Brighton, Massachusetts

Conditions: Head and Neck Cancer
Interventions: cisplatin, docetaxel, radiation therapy; Drug · Radiation
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 29
States / cities: Los Angeles, California • Decatur, Illinois • Springfield, Illinois + 20 more

Conditions: Dental Implant
Interventions: 3D R100 scanner, Conventional Radiograph; Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 85 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Pain Management
Interventions: Bupivacaine, Dexamethasone; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: HTN-Hypertension, Blood Pressure Management
Interventions: CSN electrode was implanted around tissue including CSN branches; Device
Lead sponsor: Louis Stokes VA Medical Center; Federal
Eligibility: Not listed
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cancer
Interventions: protein expression analysis, immunohistochemistry staining method, laboratory biomarker analysis, biopsy; Genetic · Other · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: Up to 120 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Bladder Cancer, Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary, Extragonadal Germ Cell Tumor, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Ovarian Cancer, Sarcoma, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: filgrastim, Amifostine, Carboplatin, Etoposide, Ifosfamide, peripheral blood stem cell transplantation; Biological · Drug · Procedure
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2002
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Anal Fistula, Crohn's Disease
Interventions: Surgisis Biodesign Anal Fistula Plug (SurgiSIS AFP); Device
Lead sponsor: Cook Group Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 3
States / cities: Los Angeles, California • New York, New York • Cleveland, Ohio

Conditions: Acetaminophen
Interventions: Acetaminophen; Drug
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Advanced Chronic Rhinosinusitis
Interventions: Propofol, Sevoflurane; Drug
Lead sponsor: Ochsner Health System; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: End Stage Renal Disease (ESRD), Vascular Access Complication
Interventions: Single Application of Adipose Derived Mesenchymal Stem Cells (AMSC), Placebo, Two Applications of Adipose Derived Mesenchymal Stem Cells (AMSC); Biological · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Vesicovaginal Fistula, Delivery of Healthcare
Interventions: Questionnaire; Other
Lead sponsor: Ascher-Walsh, Charles, M.D.; Individual
Eligibility: Female only
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: New York, New York

Conditions: End-Stage Kidney Disease, Hemodialysis Complication
Interventions: AV graft, surgical intervention for creation of a fistula; Device · Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 60 Years and older
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 7
States / cities: Birmingham, Alabama • Los Angeles, California • Baltimore, Maryland + 4 more

Conditions: Gastric Fistula
Interventions: gastro-gastric fistula closure; Procedure
Lead sponsor: Legacy Health System; Other
Eligibility: 18 Years to 85 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

Forces During Skull Base Surgery

Mucociliary Clearance Time in Chronic Rhinosinusitis (CRS) Patients After Sinus Surgery

Neurodevelopmental Outcomes and Growth in Infants With Congenital Gastrointestinal Anomalies Requiring Neonatal Surgery

The Effects of Post-Operative Interventions on Surgical Site Occurrences in AWR

Randomized Fistula Study

Xylitol for Chronic Sinusitis

Early Feeding TL Trial

Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery

Clipped Versus Handsewn Arteriovenous Fistula Anastomosis

Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal Sinus

Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge

S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer

Radiographic Changes in the Maxillary Sinus Following Closed Sinus Augmentation

Regional Anesthesia to Reduce Opioid Use Following Functional Endoscopic Sinus Surgery

Direct Carotid Sinus Nerve Stimulation in Anesthetized Human Subjects

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

High-dose ICE With Amifostine

Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft

Acetaminophen Given Per Os and Intravenous in Sinus Surgery

Total Intravenous Anesthesia in Sinus Surgery

Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure

Access to Healthcare, Patient Comprehension and Future Plans of Women Undergoing Surgery for a Vesicovaginal Fistula in Niamey, Niger

The Arteriovenous Vascular (AV) ACCESS Trial

Endoscopic Treatment of Intestinal Fistulas and Perforations